Veradigm (Veradigm) Change In Receivables : $85 Mil (TTM As of Sep. 2022)

View and export this data going back to 1999. Start your Free Trial

What is Veradigm Change In Receivables?

Veradigm's change in receivables for the quarter that ended in Sep. 2022 was $44 Mil. It means Veradigm's Accounts Receivable declined by $44 Mil from Jun. 2022 to Sep. 2022 .

Veradigm's change in receivables for the fiscal year that ended in Dec. 2021 was $-5 Mil. It means Veradigm's Accounts Receivable increased by $5 Mil from Dec. 2020 to Dec. 2021 .

Veradigm's Accounts Receivable for the quarter that ended in Sep. 2022 was $169 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Veradigm's Days Sales Outstanding for the three months ended in Sep. 2022 was 101.53.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Veradigm's liquidation value for the three months ended in Sep. 2022 was $106 Mil.

Veradigm Change In Receivables Historical Data

The historical data trend for Veradigm's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veradigm Change In Receivables Chart

Veradigm Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Receivables

Get a 7-Day Free Trial

-95.19

-120.52

-9.43

35.16

-5.00

Veradigm Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Change In Receivables	Get a 7-Day Free Trial															-30.03	13.21	26.21	2.55	43.54

Veradigm Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $85 Mil.

Veradigm (OTCPK:MDRX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Veradigm's Days Sales Outstanding for the quarter that ended in Sep. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	169.029	/	151.922	*	91
=	101.53

2. In Ben Graham's calculation of liquidation value, Veradigm's accounts receivable are only considered to be worth 75% of book value:

Veradigm's liquidation value for the quarter that ended in Sep. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	492.597	-	513.636	+	0.75 * 169.029	+	0.5 * 0
=	106

Veradigm Change In Receivables Related Terms

Thank you for viewing the detailed overview of Veradigm's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Veradigm (Veradigm) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veradigm Inc (OTCPK:MDRX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654

Website

https://www.veradigm.com

Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

Executives

Shih Yin Ho	director	222 MERCHANDISE MART, SUITE 2024, CHICAGO IL 60654
Susan Rodriguez	director	C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555
Richard J. Poulton	officer: CFO	3646 WESTFIELD LANE, GLENVIEW IL 60026
Tejal Vakharia	officer: SVP Gerneral Counsel	222 MERCHANDISE MART PLZ, SUITE 2024, CHICAGO IL 60654
David B Stevens	director	1 IMATION WAY, OAKDALE MN 55128
Leah Jones	officer: Chief Financial Officer	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Paul Black	director	400 WOOD ROAD, BRAINTREE MA 02184
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Thomas Langan	officer: President and CCO	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Lisa Hammond	officer: SVP & Chief HR Officer	305 CHURCH AT NORTH HILLS STREET, RALEIGH NC 27609
Greg Garrison	director	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Lisa Khorey	officer: Chief Client Delivery Officer	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Michael Klayko	director
Carol J Zierhoffer	director	100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Brian Farley	officer: SVP Gerneral Counsel & Corpora	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654